USPTO serial 78953646
SUMAGLIDE
Reviewed by CopyMark Law Group
Reg. 3344270Status 710
- Filing date
- Status date
- Registration date
- Nov 27, 2007
- Examiner
- DEFORD, JEFFREY S
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SUMAGLIDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Abingdon, Oxfordshire, GB
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
ABINGDON, OXFORDSHIRE, GB
Other trademarks owned by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
ABINGDON, OXFORDSHIRE, GB
Other trademarks owned by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
ABINGDON, OXFORDSHIRE, GB
Other trademarks owned by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARK HARRISON
MARK HARRISON VENABLE LLPP.O. Box 34385WASHINGTON, DC 20043UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations and substances for the diagnosis of, treatment of or protection against infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the diagnosis of, treatment of or protection against viral, bacteriological, haematological, nutritional, dermatological, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances for the treatment of or protection against infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of or protection against viral, bacteriological, haematological, nutritional, dermatological, metabolic, musculoskeletal, cardiovasclar, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances; pharmaceutical and veterinary preparations and substances for the treatment and alleviation of migraines and headaches | SECTION 8 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, namely, needle lancets, medical injectors, needle-free injectors, biological sampling apparatus namely fluid and tissue collectors and samples, and parts and fittings therefor; drug delivery devices, namely needle lancets, medical injectors, needle-free injectors and parts and fittings therefor; actuator devices for use in drug delivery devices; drug cassettes for use in drug delivery devices to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnoatic use; fluid and tissue sampling devices, namely needle lancets, fluid and tissue collectors and samplers, and parts and fittings therefor | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Caretek Medical Limited
- Other trademarks owned by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
- Other trademarks owned by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
- Other trademarks owned by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SUMAGLIDE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2018 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jan 10, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 12, 2010 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Mar 5, 2010 | PAPER RECEIVED | — | |
| Oct 2, 2009 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Feb 29, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jan 3, 2008 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Nov 27, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 26, 2007 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 26, 2007 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 18, 2007 | FAXX | FAX RECEIVED | — |
| Sep 11, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 7, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 1, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 1, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jul 13, 2007 | PAPER RECEIVED | — | |
| Jan 16, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2006 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 23, 2006 | NWAP | NEW APPLICATION ENTERED | — |